Cardiac amyloidosis: From diagnosis to therapeutics breakthroughs

doi:10.5493/wjem.v16.i1.112270

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 1

This Article

(30)

(35)

(0)

(41)

(1280)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Experimental Medicine

ISSN

2220-315x

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Exp Med. Mar 20, 2026; 16(1): 112270
Published online Mar 20, 2026. doi: 10.5493/wjem.v16.i1.112270

Full Size Figure Download Figure

Figure 2 Patient diagnosed with endomyocardial biopsy. A: T1 native mapping demonstrates abnormally high values in all entire left ventricle (LV) walls in cardiac amyloidosis; B: Diffuse transmural LV and subendocardial right ventricle (RV) late gadolinium enhancement (LGE) in two-chamber short; C: Bulls-eye map of T1 native; D: Diffuse transmural LV and subendocardial RV LGE in long axes[26]. Citation: Maggialetti N, Torrente A, Lorusso G, Villanova I, Ficco M, Gravina M, Ferrari C, Giordano L, Granata V, Rubini D, Lucarelli NM, Stabile Ianora AA, Scardapane A. Role of Cardiovascular Magnetic Resonance in Cardiac Amyloidosis: A Narrative Review. J Pers Med 2024; 14: 407. Copyright© The Authors 2024. Published by MDPI. The article is open access (Supplementary material).

Citation: Bouziane M, Moufid O, Habbal R. Cardiac amyloidosis: From diagnosis to therapeutics breakthroughs. World J Exp Med 2026; 16(1): 112270
URL: https://www.wjgnet.com/2220-315x/full/v16/i1/112270.htm
DOI: https://dx.doi.org/10.5493/wjem.v16.i1.112270

Bouziane M, Moufid O, Habbal R. Cardiac amyloidosis: From diagnosis to therapeutics breakthroughs. World J Exp Med 2026; 16(1): 112270 [PMID: 41883450 DOI: 10.5493/wjem.v16.i1.112270]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.